Recombinant Human MG53 Protein Protects Against Alkaline-Induced Corneal Injuries in Mice

重组人 MG53 蛋白可保护小鼠免受碱性诱发的角膜损伤

阅读:8
作者:Owen Guo, Brent Ju, McKinley H Shawver, Bingchuan Geng, Siqi Wei, Terriah Early, Frank Yi, Tao Tan, Heather L Chandler, Jianjie Ma, Hua Zhu

Conclusions

rhMG53 may be an effective means to treat corneal wounding.

Methods

A round filter paper with 2-mm diameter was soaked in 1 mol/L of NaOH solution. The mouse alkaline injury was generated by placing the filter paper directly on the cornea for 30 seconds and washed with 30-mL saline; 10 µL of rhMG53 solution (20 µg/mL) or saline control was topically administrated on the mouse corneas (twice per day for 10 days). Re-epithelialization was measured by fluorescein staining and imaged by a slit lamp equipped with a digital camera. Clinical neovascularization and opacity scores were measured every day after injury. Ten days after injury, mice were sacrificed and corneas were dissected out for flat mount staining of CD31 for neovascularization.

Results

MG53 was present in both dog aqueous humor and human tears. mg53-/- corneas were more susceptible to alkaline-induced corneal injury. Topical treatment of rhMG53 improved re-epithelialization, suppressed neovascularization, and fibrosis induced by alkaline injury. Conclusions: rhMG53 may be an effective means to treat corneal wounding.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。